Studies have found that high HIV viremia and low CD4+ T cell counts are associated with poor prognosis in COVID-19, with a higher risk of adverse outcomes in HIV/AIDS patients with a CD4+ T cell count below 200 cells/μL and those who have not received ART [9,10,11]. The gene discussed is CD4; the disease is AIDS.